We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Infection Surveillance in Intensive Care Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Herlev Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00197847
First Posted: September 20, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Herlev Hospital
  Purpose

Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.

As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.


Condition
Infection Pneumonia Sepsis Cross Infection

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective

Further study details as provided by Herlev Hospital:

Estimated Enrollment: 549
Study Start Date: December 2002
Estimated Study Completion Date: September 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Admission to ICU -

Exclusion Criteria:Absence of informed consent and age less than 18 years

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00197847


Locations
Denmark
Department of Intensive Care
Copenhagen, Copenhagen Couty, Denmark, DK-2730
Sponsors and Collaborators
Herlev Hospital
Investigators
Principal Investigator: Dorthe H Olsen, M.D. Department of Intensive Care, Herlev University Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00197847     History of Changes
Other Study ID Numbers: KA 02071
First Submitted: September 12, 2005
First Posted: September 20, 2005
Last Update Posted: December 9, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Infection
Communicable Diseases
Pneumonia
Cross Infection
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Iatrogenic Disease
Disease Attributes
Pathologic Processes